Login Get Started
Browse
Shares
Healthcare
Biotechnology & Medical Research
Zogenix Inc
Zogenix Inc logo

ZGNX - Zogenix Inc Share News

$22.16 -1.3  -5.4%

Last Trade - 9:00pm

Sector
Healthcare
RiskRating
Adventurous
Size
Mid Cap
Style
Sucker Stock
Market Cap £922.6m
Enterprise Value £641.6m
Revenue £5.01m
Position in Universe 2571st / 6713
Quality
Value
Momentum
StockRank™
StockReport™
Tools
Compare with... Run through checklist
Accounts
Balance sheet Income statement Cashflow statement Dividend summary
Charts News Discussions ZGNX Dividends
All News
All News Reuters News Company Announcements
BRIEF-Zogenix Reports Q4 And Full-Year 2020 Financial Results
43 mins ago News
Zogenix Provides Corporate Update and Reports Fourth Quarter and Full-Year 2020 Financial Results
9:01pm News
Zogenix to Participate in the 10th Annual SVB Leerink Global Healthcare Conference
18th Feb News
Zogenix to Release Fourth Quarter and Full-Year 2020 Financial Results and Host Conference Call and Webcast on February 25
11th Feb News
BRIEF-Zogenix's Fintepla® (Fenfluramine) Oral Solution Now Available In Germany For Treatment Of Seizures In Dravet Syndrome
1st Feb News
Zogenix’s FINTEPLA® (Fenfluramine) Oral Solution Now Available in Germany for the Treatment of Seizures in Dravet Syndrome
1st Feb News
BRIEF-Zogenix Announces Preliminary, Unaudited Q4 2020 Net Product Sales
11th Jan News
Zogenix Announces Preliminary, Unaudited Fourth Quarter 2020 Net Product Sales
11th Jan News
BRIEF-Zogenix - European Commission Approves Co's Fintepla Oral Solution For Treatment Of Seizures In Dravet Syndrome
21st Dec '20 News
The European Commission Approves Zogenix’s FINTEPLA® (Fenfluramine) Oral Solution for the Treatment of Seizures in Dravet Syndrome
21st Dec '20 News
BRIEF-Tevard Biosciences And Zogenix Announce Collaboration To Advance Novel Gene Therapies For Dravet Syndrome And Other Genetic Epilepsies
3rd Dec '20 News
Zogenix and Leading Experts to Present New Rare Epilepsy Data at AES 2020
1st Dec '20 News
Zogenix to Participate in the Stifel 2020 Virtual Healthcare Conference
11th Nov '20 News
BUZZ-Zogenix: Falls on bigger-than-expected Q3 loss
10th Nov '20 News
BRIEF-Zogenix Reports Q3 Loss Per Share $1.08
9th Nov '20 News
Zogenix Provides Corporate Update and Reports Third Quarter 2020 Financial Results
9th Nov '20 News
Zogenix Announces Date Change for Third Quarter 2020 Financial Results and Conference Call and Webcast to November 9
29th Oct '20 News
Zogenix to Release Third Quarter 2020 Financial Results and Host Conference Call and Webcast on November 10
26th Oct '20 News
BRIEF-Zogenix Receives Positive CHMP Opinion For Fintepla
16th Oct '20 News
Zogenix Receives Positive CHMP Opinion for FINTEPLA® (Fenfluramine) Oral Solution for the Treatment of Seizures in Patients with Dravet Syndrome
16th Oct '20 News
© Stockopedia 2021, Refinitiv, Share Data Services.
Youtube Instagram RSS
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.